KPC Pharmaceuticals, Inc.(600422) Key Financial Indicators

Quotes

Detailed Quotes

Company Overview

Company Profile Company Executives

Financial Analysis

Main Composition Key Indicators Financial Statement

Multi-dimentional Analyses

Company Valuation Capital Tracking Short Selling Data

YOY

Do not show

Hide blank lines

(Q3)2023/03/31(FY)2022/12/31(Q9)2022/09/30(Q6)2022/06/30

Per Share Indicator

Net Asset Per Share

4.42% 6.7455 4.18% 6.5717 5.48% 6.5555 4.40% 6.3467

Basic Earning Per Share

12.58% 0.17 -23.82% 0.51 -14.10% 0.4915 -34.76% 0.2857

Diluted Earning Per Share

12.58% 0.17 -23.82% 0.51 -14.10% 0.4915 -34.76% 0.2857

Earning Per Share

14.44% 0.1728 -24.53% 0.5053 -14.10% 0.4915 -34.76% 0.2857

Diluted Earning Per Share（TTM）

-6.42% 0.5273 -24.53% 0.5053 -17.28% 0.5888 -30.50% 0.5172

Capital Surplus Funds Per Share

-0.92% 1.5301 -0.66% 1.5312 -0.08% 1.5364 -0.01% 1.5355

Undivided Profit Per Share

6.33% 3.7543 5.95% 3.5808 7.92% 3.5987 6.02% 3.3928

Operating Cash Flow Per Share

-63.24% -0.7346 0.87% 0.3348 27.62% -0.152 -73.19% -0.3398

Enterprise FCF Per Share

84.21% -0.132 -72.32% 0.0958 19.41% -0.5543 -257.19% -0.8051

Shareholder FCF Per Share

61.22% -0.2743 46.34% 0.5321 61.52% -0.2383 -346.57% -0.5332

EBIT Per Share

14.73% 0.2306 -22.36% 0.6752 -9.32% 0.6587 -30.93% 0.3741

Profitability

ROE Weighted

10.17% 2.600% -28.27% 7.890% -19.37% 7.620% -38.54% 4.450%

ROE

9.65% 2.562% -27.55% 7.690% -18.57% 7.498% -37.52% 4.501%

ROA

10.19% 1.437% -30.26% 4.207% -20.44% 4.229% -40.21% 2.437%

ROIC

5.21% 2.258% -28.72% 6.904% -17.54% 6.871% -37.64% 3.941%

Net Profit Ratio

42.06% 7.027% -25.15% 4.654% -15.38% 6.140% -36.96% 5.166%

Gross Income Ratio

22.87% 44.161% 0.52% 41.516% 0.70% 42.868% -4.74% 41.228%

EBIT To Total Operating Revenue

41.92% 9.152% -22.63% 6.181% -11.73% 8.066% -33.13% 6.710%

Period Costs Rate

22.33% 34.643% -0.34% 35.252% -0.04% 35.460% -2.15% 34.416%

Operating Expense Rate

25.18% 28.797% 2.14% 29.372% -1.75% 29.260% -4.38% 28.476%

Admini Expense Rate

26.74% 4.642% -6.88% 4.577% -4.09% 4.479% -7.88% 4.104%

Financial Expense Rate

-18.76% 0.340% -3.81% 0.463% 23.32% 0.529% 57.15% 0.546%

Recurrent Net Profit

-2.67% 103.45M -10.17% 251.11M 0.79% 259.64M -28.69% 144.41M

Operating Profit Ratio

47.44% 8.880% -21.86% 6.003% -13.70% 7.560% -35.66% 6.339%

EBIT

14.69% 174.81M -22.36% 511.95M -9.31% 499.48M -30.93% 283.65M

Solvency

Current Ratio

0.59% 1.8411 -1.88% 1.7399 -1.86% 1.8105 -3.58% 1.7369

Quick Ratio

7.49% 1.3599 6.08% 1.3078 5.87% 1.3059 0.09% 1.2317

Debt Equity Ratio

-4.06% 75.437% 4.25% 83.411% 8.24% 77.137% 9.19% 81.722%

Interest Cover（T）

74.71% 26.9567 -36.99% 14.7695 -28.42% 15.2349 -62.69% 17.6434

Shareholders Equity Without Minority Interests To Total Liabilities

4.45% 128.651% -4.01% 116.170% -7.57% 125.557% -8.28% 118.516%

Shareholders Equity Without Minority Interests To Interest Bear Debt

11.89% 626.5309% -27.53% 445.8484% -15.74% 498.9038% -28.77% 453.9796%

Long Debt To Working Capital

-26.14% 0.135 -19.73% 0.1392 -8.58% 0.148 -3.49% 0.1607

Growth Ability

Average Net Profit YOY Past Five Year

-41.72% 14.494% 93.02% 5.957% 93.47% 7.224% 415.96% 8.833%

Sustainable Grow Rate

10.20% 2.693% 17.11% 8.058% -19.11% 7.950% -39.42% 4.565%

Operating Capacity

Operating Cycle（D/T）

36.94% 268.1685 10.32% 225.966 11.95% 237.4443 12.23% 230.9604

Inventory Turnover Days（D/T）

25.79% 143.3827 -1.00% 132.4555 0.15% 139.9318 -1.15% 134.6728

Accounts Receivable Turnover Days（D/T）

52.47% 124.7858 31.66% 93.5105 34.75% 97.5125 38.42% 96.2877

Inventory turnover Rate（T）

-20.50% 0.6277 1.01% 2.7179 -0.14% 1.9295 1.17% 1.3366

Accounts Receivable Turnover Rate（T）

-34.42% 0.7212 -24.05% 3.8498 -25.79% 2.7689 -27.76% 1.8694

Current Assets Turnover Rate（T）

-24.27% 0.2864 -9.00% 1.2794 -8.61% 0.9845 -7.11% 0.6771

Total Assets Turnover Rate（T）

-22.45% 0.2045 -6.33% 0.9039 -5.45% 0.6887 -4.63% 0.4718

Fixed Assets Turnover Rate（T）

-- -- 3.89% 6.8872 -- -- 5.17% 3.472

Equity Turnover Rate（T）

-22.53% 0.3783 -5.12% 1.696 -3.49% 1.2698 -2.48% 0.8811

Cash Position

Free Cash Flow

84.22% -100.07M -72.32% 72.63M 19.41% -420.28M -257.21% -610.49M

Net Profit Cash Cover

-42.17% -414.934% 34.34% 65.868% 16.75% -30.310% -165.94% -117.973%

Operating Revenue Cash Cover

-13.89% 69.755% -5.80% 100.934% -5.55% 94.448% -13.17% 85.496%

Operating Cash In To Assets

-56.66% -5.964% -5.81% 2.771% 33.40% -1.282% -59.87% -2.875%

Dividend Ability

Retained Earning Ratio

0.00% 100.000% 67.58% 100.000% 0.00% 100.000% 0.00% 100.000%

Capital Structure

Debt Assets Ratio

-2.31% 43.000% 2.32% 45.478% 4.65% 43.547% 5.06% 44.971%

Current Assets To Total Assets

1.63% 71.092% 3.23% 71.739% 4.25% 70.397% 2.66% 69.839%

Non Current Assets To Total Assets

-3.80% 28.908% -7.35% 28.261% -8.83% 29.603% -5.65% 30.161%

Fix Assets Ratio

-- -- -10.99% 12.382% -- -- -9.87% 13.268%

Interest Bearing Debt To Total Capital

-9.04% 13.413% 31.29% 17.853% 15.69% 16.257% 33.47% 17.583%

Yield Quality

Invest Revenue From Associates To Total Profit

-86.62% -0.029% 28.03% -0.053% 573.85% 0.207% -3,073.87% -0.352%

Net Income From Value Changes To Total Profit

518.70% 11.283% -85.28% 3.490% -60.95% 9.963% -53.01% 15.107%

Recurrent Net Profit To Net Profit

-15.21% 77.082% 19.60% 65.146% 15.94% 68.279% 9.52% 66.131%

Dupont Analysis

Equity Multipler_DuPont

-0.11% 1.850% 1.28% 1.876% 2.08% 1.844% 2.27% 1.868%

Net Profit of Parent Company OwnersTo Net Profit_DuPont

-0.29% 97.628% 0.50% 99.410% -1.19% 98.008% 0.18% 99.189%

Net Profit To Total Operating Revenue_DuPont

42.06% 7.027% -25.15% 4.654% -15.38% 6.140% -36.96% 5.166%

Net Profit To Total Profit_DuPont

-2.78% 79.734% -0.66% 80.761% -2.22% 81.478% -2.18% 81.614%

Total Profit To EBIT_DuPont

2.96% 96.290% -2.62% 93.229% -1.96% 93.436% -3.63% 94.332%

EBIT To Total Operating Revenue_DuPont

41.92% 9.152% -22.63% 6.181% -11.73% 8.066% -33.13% 6.710%

Currency Unit

CNYCNYCNYCNY

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report，MOM=(current period - last period)/last period *100%

Company Overview More

Procurement, production and sale of raw materials and preparations of Chinese and Western medicine, chemical raw materials, intermediates, reagents, packaging materials, extracts, Chinese medicine tablets, agricultural by-products and Chinese herbal medicines (cultivation, acquisition and sale), industrial hemp cultivation, R&D, flower and leaf processing, domestic trade, material supply and marketing, goods and technology import and export business, technology development, consulting services, mechanical processing, pharmaceutical equipment manufacturing, installation and maintenance business, pharmaceutical engineering design, medical device management, foreign aid projects.

CEO： --

Market： --

Listing Date： 12/06/2000

Futu Hot List

CNHKUS

SearchNews

SymbolLatest price%Chg

Watchlist